This section of the website is currently under development. This means some parts may not work properly and some documents referred to may not be accessible yet. Please bear with us as we make the website as accessible as possible.
Document library
- Adult Focal Epilepsy treatment pathway FINAL - October 2020
- Agomelatine for depression – primary care factsheet March 2023
- Allergic rhinitis pathway - June 2019
- Anal Fissure pathway FINAL - May 2018
- Antidepressant in pregnancy guidance – August 2022
- Antidepressant in pregnancy poster – August 2022
- Asthma guidelines SEL FINAL - April 2019
- Atopic dermatitis - Dupilumab outcomes framework - July 2021
- Atopic dermatitis – dupilumab pathway FINAL - June 2021
- Care Homes - Anticoagulant best practice guidance April 2023
- Care Homes – safe use of PRN medicines guidance June 2022
- Constipation (chronic) guideline SEL FINAL - April 2021
- COPD guideline SEL updated FINAL - December 2020
- Delmosmart for methylphenidate MR switch leaflet FINAL
- Dermatology Guidelines for Primary Care FINAL – October 2022
- Dermatology Specials fact sheet - Beclometasone diproprionate - Decemeber 2017
- Dermatology Specials fact sheet - clobetasol propionate - December 2017
- Dermatology Specials fact sheet - Lactic acid in Diprobase cream - December 2017
- Dermatology Specials fact sheet - Monobenzone in cetomacrogol - December 2017
- Emollient Guideline FINAL – May 2023
- Emollients patient information leaflet – May 2023
- Emollients patient letters template
- Environmental Impact of Inhalers Patient Information December 2021
- Environmental Impact of Inhalers Position Statement December 2021
- Erectile dysfunction treatment guidance FINAL - December 2020
- Gastroparesis treatment pathway Adults FINAL - October 2020
- Glaucoma - Ocular Hypertension treatment pathway - January 2018
- Gout Primary Care Management Guideline January 2022
- Guidance HPV vaccine anogenital warts FINAL - December 2021
- Hyperhidrosis pathway - November 2018
- Hypersalivation management options FINAL - September 2019
- IBD dose escalated anti-TNF therapy (Crohn’s Disease) March 2022
- IBD dual biologic therapy (Crohn’s Disease) March 2022
- IBD Pathway Monitoring Framework 2022
- IBD pathways with Fe deficiency pathway FINAL – December 2022
- Immune Thrombocytopenia (ITP) adult Pathway FINAL - July 2020
- Intravitreal pathway - April 2018
- Irritable Bowel Syndrome Pathway (adults) FINAL - July 2020
- Jorveza for eosinophilic oesophagitis – GP information leaflet March 2023
- Lidocaine Plasters Deprescribing Guide FINAL June 2022
- Management of Adult Non-Cancer Chronic Pain - March 2019
- Management of Motor Symptoms in Parkinson's Disease - July 2018
- Methotrexate 10mg tabs template letters - August 2021
- Neuropathic Pain (Adults) guidance FINAL June 2022
- Neuropathic pain (refractory) AED meds info - Adults - FINAL - July 2020
- NICE and SPS Clinical guidance Covid-19 FINAL
- Nystatin for early voice prosthesis failure - GP information leaflet
- Oral medicine treatments (off label) GUIDE Jan 19
- Overactive bladder (OAB) adults pathway - February 2020
- Papulopustular Rosacea treatment pathway - March 2019
- Pseudomonas guideline NON-CF Bronchiectasis Nov 21 FINAL
- Psoriasis Biologic Pathway - Adults - FINAL - January 2022
- Psoriasis Pathway Outcomes Monitoring Framework FINAL - January 2022
- Reconciling hospital only medicines in primary care FINAL - October 2020
- Reconciling hospital only medicines in primary care FINAL - October 2020
- Respimat Reusable Inhaler Factsheet December 2021
- Restless Legs Syndrome GP fact sheet - May 2017
- Restless Legs Syndrome patient leaflets
- Restless Legs Syndrome Treatment Pathway update FINAL - February 2020
- Rheumatoid arthritis pathway FINAL – November 2022
- Rheumatology Monitoring Framework FINAL - August 2021
- SEL Malnutrition and ONS prescribing guide
- Seronegative spondyloarthropathy pathway FINAL – November 2022
- Sleep - Cataplexy with narcolepsy pathway – March 2023
- Sleep - GP information on Sleep Hygiene
- Sleep - Narcolepsy GP fact sheet - August 2018
- Sleep - Narcolepsy pathway - August 2018
- Sleep - Non-REM Medicines Information – March 2023
- Sleep - Non-REM parasomnia pathway – March 2023
- Sleep - Non-REM parasomnias GP and Community Pharmacy fact sheet – March 2023
- Sleep - RBD behaviour GP and Community Pharmacy fact sheet – March 2023
- Sleep - RBD medicines information – March 2023
- Sleep - REM Behaviour Disorder pathway – March 2023
- Sleep – Co-morbid insomnia pathway – March 2023
- Steroid Safety – Adrenal Insufficiency Patient Information Leaflet February 2023
- Steroid Safety – Steroid Emergency Card Guidance for Primary Care February 2023
- Stoma care review letter template FINAL
- Stoma Care transfer of care letter template FINAL
- STOMP and STAMP Guidance SEL FINAL - July 2020
- Testosterone gel or sachets for menopause leaflet FINAL - June 2019
- Ulipristal Acetate (Esyma) interim statement - February 2018
- Urticaria Treatment Pathway FINAL - December 2018
- Valproate GP actions flyer - September 2018
- Vitamin D guidelines for adults FINAL - July 2020
- Vitamin D patient information leaflet FINAL - July 2020
- Xenidate for methylphenidate MR switch leaflet FINAL